Cardiol Therapeutics Announces Over $7M In Proceeds From Warrant Exercises, Extending Cash Runway Into H1 2028; Issues Acceleration Notice On 425,000 Remaining Warrants, Expiring October 16

Benzinga Newsdesk www.benzinga.com Positive 88.8%

Neg 0% Neu 0% Pos 88.8%

Comments

No comments yet. Be the first!